Conceptio › Archive › HAL (France)
HAL (France)open access

An integrated Phase II/III randomized study comparing durvalumab and tremelimumab ± Hepatic ArteriaL infusion chemotherapy with GEMOX in hepatocellular Carcinoma with high tumor burdEn – ALICE (PRODIGE89 – UCGI44 – ALICE)

Octave Letissier et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
hepatocellular-carcinomaimmunotherapy
Hepatocellular carcinoma, 2, 0, Hepatic arterial infusion chemotherapy, Portal vein tumour thrombosis, 1, Immunotherapy
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 983854
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.